• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by PetVivo Holdings Inc.

    4/4/25 4:40:47 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care
    Get the next $PETV alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    PetVivo Holdings, Inc.

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)


    716817408

    (CUSIP Number)


    03/31/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox not checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    716817408


    1Names of Reporting Persons

    CRUDEN STANLEY C
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    2,413,470.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    2,413,470.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    2,413,470.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    10.1 %
    12Type of Reporting Person (See Instructions)

    IN


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    PetVivo Holdings, Inc.
    (b)Address of issuer's principal executive offices:

    5151 Edina Industrial Blvd, Edina, MINNESOTA, 55439
    Item 2. 
    (a)Name of person filing:

    Stanley C. Cruden
    (b)Address or principal business office or, if none, residence:

    1135 Calgary Rd. North Port, FL 34288
    (c)Citizenship:

    USA
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP No.:

    716817408
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    2,413,470
    (b)Percent of class:

    10.1  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    2,413,470

     (ii) Shared power to vote or to direct the vote:

    0

     (iii) Sole power to dispose or to direct the disposition of:

    2,413,470

     (iv) Shared power to dispose or to direct the disposition of:

    0

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    CRUDEN STANLEY C
     
    Signature:Stanley C. Cruden
    Name/Title:Stanley C. Cruden
    Date:04/04/2025
    Get the next $PETV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PETV

    DatePrice TargetRatingAnalyst
    10/12/2021$7.00Buy
    ThinkEquity
    More analyst ratings

    $PETV
    Leadership Updates

    Live Leadership Updates

    See more
    • PetVivo Engages Former Dechra North American President, Mike Eldred as Commercial and Operations Advisor

      PetVivo Board Appoints Eldred as Executive Director to Lead Company Product Commercialization and Operations MINNEAPOLIS, MN, Jan. 27, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, PETVW)), a leading provider of biomedical therapeutics for equines and companion animals, has appointed Mike Eldred as the Company's Commercialization and Operations Advisor. His appointment as an Executive Director by the Company's Board of Directors draws upon Mr. Eldred's 30 years of executive experience in animal health and the veterinary industry to ramp up its product development and sales efforts. For the past 20 years, Mr. Eldred served as President of North American Operations for Dech

      1/27/25 9:29:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • PetVivo Engages Another Top Sales Manager, Cindy Gill, for Regional Business Development Manager, as Adoption of Breakthrough Animal MedTech Device Continues to Spread Nationwide

      MINNEAPOLIS, MN, Oct. 21, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, PETVW))), a leading provider of biomedical therapeutics for equines and companion animals, has appointed Cindy Gill to the position of field veterinary business development manager for the entire states of Oklahoma and Arkansas and the northern region of Texas. "Cindy's experience and strong record of sales achievement with veterinary clinics brings to our sales team a valuable resource for achieving our business goals," PetVivo CEO, John Lai. "Her experience with other veterinary products and her knowledge of clinic operations enables her to prioritize and better address the veterinarians and cli

      10/21/24 9:45:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • PetVivo Taps Top Sales Executive, Skylor Walker, for Regional Business Development Manager, as Adoption of Breakthrough Animal MedTech Device Continues to Spread Nationwide

      MINNEAPOLIS, MN, Sept. 16, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, PETVW))), a leading provider of biomedical therapeutics for equines and companion animals, has appointed Skylor Walker to the new position of field veterinary business development manager for the entire state of Louisiana and the southern region of Texas. "Skylor's experience and strong record of sales achievement with veterinary clinics brings to our sales team a valuable resource for achieving our business goals," PetVivo CEO, John Lai. "Her experience with other hydrogel injectable products enables us to prioritize and better address the veterinarians and clinics in our sales pipeline."

      9/16/24 8:00:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care

    $PETV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Lowenthal Garry N was granted 75,000 shares (SEC Form 4)

      4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

      4/15/25 4:36:36 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • Chief Executive Officer Lai John was granted 100,000 shares (SEC Form 4)

      4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

      4/15/25 4:34:14 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • Chief Financial Officer Lowenthal Garry N was granted 160,904 shares (SEC Form 4)

      4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

      1/27/25 6:27:15 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care

    $PETV
    SEC Filings

    See more

    $PETV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $PETV
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $PETV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • PetVivo Holdings Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Entry into a Material Definitive Agreement

      8-K - PetVivo Holdings, Inc. (0001512922) (Filer)

      5/7/25 11:48:49 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • SEC Form 8-K filed by PetVivo Holdings Inc.

      8-K - PetVivo Holdings, Inc. (0001512922) (Filer)

      4/8/25 3:35:35 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • SEC Form SCHEDULE 13G filed by PetVivo Holdings Inc.

      SCHEDULE 13G - PetVivo Holdings, Inc. (0001512922) (Subject)

      4/4/25 4:40:47 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • ThinkEquity initiated coverage on PetVivo Holdings with a new price target

      ThinkEquity initiated coverage of PetVivo Holdings with a rating of Buy and set a new price target of $7.00

      10/12/21 11:03:37 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH EQ ESPECIALIDADES

      MINNEAPOLIS, April 16, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, OTC:PETVW) ("PetVivo"), an emerging biomedical device company focused on the commercialization of innovative medical devices and other therapeutics for equine and companion animals, announced today it has entered into a definitive distribution agreement with Eq Especialidades ("Eq Especialidades"). Eq Especialidades will inventory, market and promote PetVivo's veterinary medical device, Spryng™ with OsteoCushion™ technology, throughout Mexico. Eq Especialidades sales and marketing activities will commence on April 1, 2025. SPRYNG® with OsteoCushion® Technology, is an intra-articular injectable veterinary m

      4/16/25 9:30:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • PETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF SERIES B CONVERTIBLE PREFERRED STOCK OFFERING

      MINNEAPOLIS, March 31, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, OTC:PETVW) and its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively "PetVivo" or the "Company") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for horses, dogs and other companion animals announced today that the Company has recently entered into a Subscription Agreement to receive Five Million Dollars ($5,000,000) of equity financing in exchange for Five Million shares of Series B Convertible Preferred Stock ("Shares") (the "Offering"). The Company initially received Six Hundred Thousand Dollars ($600,000) of the Offering proceeds

      3/31/25 8:00:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • Petvivo Holdings, Inc. and Digital Landia Corp. Announce Groundbreaking Strategic Alliance Agreement to Pioneer Agentic AI for Animal Communication

      MINNEAPOLIS, March 03, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, OTC:PETVW) (the "Company" or "PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for animals and Digital Landia Corp. a pioneer in Agentic AI solutions, today announced a transformative strategic alliance agreement. The collaboration centers on Pet AI, Digital Landia's revolutionary open-source platform that deciphers animal behavior through real-time analysis of vocalizations, body language, and physiological signals captured via smartphone cameras. This technology, which achieves 97% accuracy in translating animal communication,

      3/3/25 8:00:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by PetVivo Holdings Inc.

      SC 13G/A - PetVivo Holdings, Inc. (0001512922) (Subject)

      11/19/24 3:38:53 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by PetVivo Holdings Inc.

      SC 13G - PetVivo Holdings, Inc. (0001512922) (Subject)

      11/4/24 1:57:37 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by PetVivo Holdings Inc.

      SC 13G/A - PetVivo Holdings, Inc. (0001512922) (Subject)

      10/1/24 5:26:09 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care

    $PETV
    Financials

    Live finance-specific insights

    See more
    • PetVivo Reports Fiscal Q3 2025 Results

      MINNEAPOLIS, MN, US, Feb. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, OTC:PETVW), a leading biomedical company delivering innovative therapeutics and medical devices for equines and companion animals, reported results for its fiscal third quarter ended December 31, 2024. All comparisons are to the same year-ago period unless otherwise noted. The company will hold a conference call today at 3:00 p.m. Eastern time to discuss the results for the period (see dial-in information below). Fiscal Q3 2025 Financial Highlights Revenues totaled $583,000, up 191% sequentially and declined 2% from the same year ago period, reflecting the company's continued efforts from targetin

      2/14/25 3:10:00 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024

      MINNEAPOLIS, MN, US, Feb. 11, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, OTC:PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, will report financial results on Friday, February 14, 2025 after market close. The company will host a conference call to discuss these results at 2:00 p.m. CT (3:00 p.m. ET) on the same day. Attendees of the live webcast of the conference call and related earnings release materials can register and access the webcast on PetVivo's Investor Relations website at: https://audience.mysequire.com/webinar-view?webinar_id=b5c71aaf-5545-4297-93c3-e23bfb001608. A replay of the

      2/11/25 10:15:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • PETVIVO HOLDINGS, INC. TO HOST SHAREHOLDERS UPDATE MEETING ON JANUARY 8, 2025

      MINNEAPOLIS, MN, US, Dec. 30, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, will host a live webcast Shareholders Update Meeting to provide an overview of the Company's progress in the 2025 fiscal year and a look into the potential future of the Company. The Shareholders Update Meeting: 2025 Company Overview will be held on Wednesday, January 8, 2025 at 3:30 p.m. CT (4:30 p.m. ET). Attendees of the Shareholders Update Meeting live webcast and conference call can register and access the webcast on PetVivo's Investor Relations website at: https://audience.m

      12/30/24 10:23:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care

    $PETV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Lai John bought $90,000 worth of shares (150,000 units at $0.60), increasing direct ownership by 13% to 1,288,592 units (SEC Form 4)

      4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

      4/17/24 5:28:07 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care